• Company
• Daewoong Nabota has obtained an item license in Singapore
• by Kim, Jin-Gu Feb 13, 2023 05:59am

• Company
• Generic for Dukarb is coming soon
• by Kim, Jin-Gu Feb 13, 2023 05:58am

• Company
• GC Pharma reinforces sales partnerships
• by Kim, Jin-Gu Feb 13, 2023 05:58am

• Company
• Can Jakavi be reimbursed for GvHD within the year?
• by Eo, Yun-Ho Feb 13, 2023 05:58am

• Policy
• MFDS prepares a cost-sharing plan
• by Lee, Hye-Kyung Feb 10, 2023 05:53am

• Policy
• MenQuadfi has entered the licensing process
• by Lee, Hye-Kyung Feb 10, 2023 05:53am

• Policy
• Rosuvastatin 2.5mg/Ezetimibe, Hanmi from Daewoong,& Yuhan
• by Lee, Tak-Sun Feb 10, 2023 05:53am

• Company
• One step left to Dupixent’s reimb in pediatric patients
• by Eo, Yun-Ho Feb 10, 2023 05:53am

• Policy
• MOHW opposes legislating premium pricing for KIPC drugs
• by Lee, Jeong-Hwan Feb 10, 2023 05:53am

• Company
• Botulinum Xeomin can be stored at room temperature
• by Jung, Sae-Im Feb 10, 2023 05:52am